Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells

B Hausott1, H Greger, B Marian

  • 1Institute of Cancer Research, University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.

Insights

Plant lignans induce apoptosis in colorectal cancer cells. Nordihydroguaiaretic acid (NDGA) demonstrated potent growth inhibition, suggesting lignans

Area of Science:

  • Natural Products Chemistry
  • Molecular Biology
  • Oncology

Background:

  • Colorectal cancer remains a significant health concern.
  • Plant-derived compounds are explored for therapeutic potential.
  • Lignans are a class of natural products with diverse biological activities.

Purpose of the Study:

  • To investigate the effects of plant-derived lignans on colorectal adenoma and carcinoma cells.
  • To identify specific lignans with potent anti-cancer properties.
  • To elucidate the mechanisms underlying lignan-induced cell death.

Main Methods:

  • Cell culture of colorectal adenoma and carcinoma cell lines.
  • Assessment of cell viability and growth inhibition (IC50 determination).
  • Mitochondrial membrane potential (MMP) assays.
  • Western blot analysis for apoptosis-related proteins (bcl-xl, bcl2, caspase 3).
  • Cell cycle analysis using flow cytometry.

Main Results:

  • Lignans induced significant cell loss via apoptosis in colorectal cancer cells.
  • Nordihydroguaiaretic acid (NDGA) exhibited the strongest growth inhibition (IC50 = 1.9 μg/mL).
  • Lignans caused a time- and dose-dependent decrease in MMP and downregulation of bcl-xl.
  • NDGA treatment led to cell cycle arrest at the G2/M phase.
  • Bcl2 and caspase 3 were not implicated in the observed apoptosis.

Conclusions:

  • Naturally occurring lignans possess potent anti-proliferative and pro-apoptotic effects on colorectal cancer cells.
  • NDGA is a promising candidate for colorectal tumor therapy and chemoprevention.
  • Lignan-induced apoptosis involves modulation of MMP and bcl-xl, independent of Bcl2 and caspase 3.
  • Further research into lignans could lead to novel strategies for colorectal cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...